Stocks
Hepion Pharmaceuticals, Inc.HEPA
NASDAQHealthcareBiotechnology$0.06+3.33%
Focused on developing therapies for chronic liver diseases, this biopharmaceutical company leverages its proprietary AI platform to identify drug candidates and optimize clinical trials. Investors track its progress due to its pipeline targeting unmet medical needs in fibrosis and hepatocellular carcinoma.
Market Cap: $720,46052W Range: $0.03 – $1.15
Congressional Interest in Hepion Pharmaceuticals, Inc. (HEPA)
No congressional trades have been disclosed for Hepion Pharmaceuticals, Inc. (HEPA) yet. All data is sourced from STOCK Act periodic transaction reports filed with Congress.
Total Disclosures
0
Unique Politicians
0
Buys
0
Sells
0
Who in Congress Is Trading HEPA?
No congressional trades found for this stock.